About: http://webisa.webdatacommons.org/262407682

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	The Company is focused on development of safe, selective inhibitors of histone deacetylases (HDACs) active in the treatment of cancer, neurodegeneration, autoimmune disease and other life-threatening diseases.
http://www.w3.org/ns/prov#wasQuotedFrom	acetylon.com